30–40%
GDM prevalence in GCC
≥35
Advanced maternal age threshold
36 wk
Group B Strep screening
Gestational Diabetes Mellitus (GDM)
GDM prevalence in GCC countries (UAE, Saudi Arabia, Kuwait) ranges from 30–40% — among the highest globally — driven by high rates of obesity, sedentary lifestyle, and consanguinity. Early identification and tight glycaemic control are paramount.
Screening & Diagnosis
- 75g Oral Glucose Tolerance Test (OGTT) at 24–28 weeks
- Earlier screening at booking if risk factors (obesity, previous GDM, family history)
- Fasting ≥5.1 mmol/L or 1h ≥10.0 or 2h ≥8.5 mmol/L = GDM (IADPSG criteria)
Blood Glucose Targets
- Fasting <5.3 mmol/L
- 1h post-meal <7.8 mmol/L
- 2h post-meal <6.7 mmol/L
Management Ladder
- Step 1 — Diet & lifestyle: low GI diet, 30 min moderate exercise daily, 3 main meals + 2–3 snacks; review by dietitian within 1 week of diagnosis
- Step 2 — Metformin: if targets not met within 1–2 weeks; safe in pregnancy, excreted in breast milk at low levels
- Step 3 — Insulin: if metformin insufficient or not tolerated; fasting hyperglycaemia → basal insulin (e.g. Isophane/NPH at night); post-meal hyperglycaemia → rapid-acting (NovoRapid/Humalog) with meals
Gestational Hypertension & Pre-Eclampsia Risk
Definition
BP ≥140/90 mmHg on two occasions at least 4 hours apart, arising after 20 weeks gestation in a previously normotensive woman.
- Gestational hypertension: raised BP without proteinuria or other organ involvement
- Pre-eclampsia: hypertension + proteinuria OR severe features (see Tab 2)
- GCC risk factors: nulliparity, obesity, multiple pregnancy, IVF conception, previous pre-eclampsia
- Aspirin 150 mg at night from 12 weeks if high risk (≥2 moderate or ≥1 high risk factor)
Multiple Pregnancy
GCC has some of the world's highest IVF utilisation rates (UAE, Saudi Arabia). Twin and higher-order pregnancies are significantly elevated compared to global averages.
Key Complications
- Preterm birth (50% of twins deliver <37 weeks)
- Fetal growth restriction (FGR)
- Twin-to-twin transfusion syndrome (TTTS) — monochorionic twins only
- Pre-eclampsia risk ×3 vs singleton
- Malpresentation at delivery
Chorionicity Surveillance
- Determine at 11–14 week USS
- Monochorionic diamniotic (MCDA): USS every 2 weeks from 16 weeks
- TTTS: discordant AF, donor/recipient features — refer for laser ablation
- Dichorionic: USS every 4 weeks from 20 weeks
Advanced Maternal Age (≥35 years) & Previous CS
AMA Risk Considerations
- Trisomy 21 risk rises sharply: 1:270 at 35, 1:85 at 40 years
- Offer cell-free DNA (cfDNA) or combined screening
- Higher rates of GDM, hypertension, placenta praevia
- Increased CS rate — surgical risk counselling
VBAC Decision-Making
- VBAC success rate ~72–75% for women with 1 previous lower-segment CS
- Uterine rupture risk: ~0.5% with VBAC vs <0.02% with ERCS
- Contraindications: previous classical/T-incision, 2+ CS, previous uterine rupture
- Continuous EFM mandatory during VBAC labour
- Grand multiparity (≥5 births): uterine atony, PPH, placenta praevia — senior review
Routine Maternal Monitoring
| Parameter | Method | Action Threshold |
|---|
| Blood pressure | Manual or validated auto device | ≥140/90 — re-check in 4h; ≥160/110 — treat within 30–60 min |
| Urine protein | Dipstick; if ≥1+ → 24h urine or PCR | PCR ≥30 mg/mmol or 24h protein ≥300 mg = significant |
| Fundal height | Tape measure (cm) from pubic symphysis | <10th or >90th centile → USS for growth |
| Fetal movements | Maternal report; if reduced → CTG/BPP | Any maternal concern — do not use kick charts alone to reassure |
| Group B Strep | Low vaginal + rectal swab at 35–37 weeks | GBS positive → IV Benzylpenicillin in labour (Clindamycin if allergic) |
Obstetric Emergency — Know These Criteria
Pre-eclampsia is the leading cause of maternal and perinatal morbidity in GCC. Prompt recognition and Mg sulphate administration saves lives. The only cure is delivery of the placenta.
Diagnostic Criteria
Pre-Eclampsia
- BP ≥140/90 mmHg after 20 weeks (×2, 4h apart)
- PLUS proteinuria (PCR ≥30 mg/mmol OR 24h ≥300 mg)
- OR any severe feature without proteinuria
Severe Features (any one)
- BP ≥160/110 mmHg
- Platelets <100,000 /µL
- Creatinine >97 µmol/L
- ALT or AST >2× upper limit of normal
- Pulmonary oedema
- New onset headache unresponsive to analgesia
- Visual disturbances (flashing lights, blurred vision)
- Epigastric / RUQ pain (hepatic capsule stretching)
HELLP Syndrome
H — Haemolysis | EL — Elevated Liver Enzymes | LP — Low Platelets
HELLP is a life-threatening variant of severe pre-eclampsia. May present WITHOUT hypertension or proteinuria. Mortality 1–3%; correct platelet threshold for delivery is platelets <50,000. Requires immediate delivery regardless of gestation.
- Symptoms: nausea, vomiting, epigastric pain, malaise — often misdiagnosed as gastritis
- LDH >600 IU/L; schistocytes on peripheral blood film
- Coagulopathy and DIC may co-exist — check full coag screen, fibrinogen
- Give dexamethasone 10 mg IV 12-hourly if <34 weeks for fetal lung maturity
Magnesium Sulphate Protocol
Loading Dose
4g MgSO₄ in 100 mL Normal Saline IV over 20 minutes
Maintenance Infusion
1g/hour continuous IV infusion; continue for 24 hours after delivery or last seizure (whichever is later)
Mandatory Monitoring (Hourly)
- Respiratory rate ≥12 breaths/min
- Urine output ≥25 mL/hour (via IDC)
- Patellar reflex MUST be present
- Oxygen saturation >95%
- Level of consciousness
Toxicity Levels
| Mg Level (mmol/L) | Clinical Effect | Action |
|---|
| 2.0–3.5 | Therapeutic (seizure prophylaxis) | Continue infusion |
| 3.5–5.0 | Nausea, flushing, diplopia | Monitor closely, reduce rate |
| 5.0–7.0 | Loss of patellar reflex — STOP infusion | Stop immediately, monitor |
| 7.0–10.0 | Respiratory depression | STOP + give antidote |
| >10.0 | Cardiac arrest | STOP + CPR + antidote |
Antidote — Calcium Gluconate
1g IV (10 mL of 10% solution) over 10 minutes. Always keep at the bedside during Mg infusion.
Magnesium Level Interpreter
Antihypertensive Therapy in Severe Hypertension
Target: reduce BP to 140–150 / 90–100 mmHg. Avoid rapid drops — may cause fetal distress. Treat within 30–60 minutes of confirmed severe hypertension.
| Drug | Route & Dose | Notes |
|---|
| Labetalol | 20–80 mg IV bolus; or 1–2 mg/min infusion | First-line IV; avoid in asthma, heart block |
| Hydralazine | 5–10 mg IV bolus, repeat every 20 min | Risk of reflex tachycardia; preload with 500 mL crystalloid |
| Nifedipine | 10–20 mg oral (immediate release) | Oral first-line if IV not immediately available; do NOT give sublingual |
Eclampsia Management
Eclampsia = Seizures in a Pre-Eclamptic Patient (may occur postnatally)
- Call for HELP — obstetric emergency team
- Place in LEFT LATERAL position — prevent aortocaval compression and aspiration
- Protect airway — jaw thrust, suction, do NOT put anything in mouth
- High-flow O₂ via face mask (15 L/min)
- MgSO₄ 4g IV over 5–10 minutes (eclampsia bolus — faster than prophylaxis dose)
- If already on Mg maintenance — give further 2g IV bolus
- If seizure continues after 2nd Mg dose — diazepam 10 mg IV or thiopentone
- Establish IV access × 2, bloods: FBC, U&E, LFTs, clotting, crossmatch
- Continuous fetal monitoring — may show bradycardia during/after seizure (usually self-resolves)
- Stabilise then plan delivery — mode depends on gestation and clinical status
PPH is the Leading Cause of Maternal Death Worldwide
Early recognition and systematic response using the 4 T's framework prevents death. Blood loss is consistently under-estimated — use weighed swabs and quantified collection where possible.
Antepartum Haemorrhage (APH)
| Cause | Clinical Features | Emergency Management |
|---|
| Placenta Praevia |
Painless, bright red bleeding; soft uterus; presenting part high/unstable |
NO vaginal exam IV access × 2; crossmatch; steroids if <34 wks; CS delivery |
| Placental Abruption |
Painful dark bleeding; rigid/woody uterus; fetal distress; concealed haemorrhage possible |
IV access; resuscitate; emergency delivery (CS or expedited vaginal); DIC risk — check clotting |
| Vasa Praevia |
Painless bleeding at membrane rupture; sinusoidal CTG; fetal exsanguination within minutes |
EMERGENCY CS — fetal blood loss. Apt test to differentiate fetal vs maternal blood |
Postpartum Haemorrhage (PPH) — 4 T's Framework
Definitions
Primary PPH: >500 mL within 24h of birth
Major PPH: >1000 mL
Massive PPH: >2000 mL or ongoing haemorrhage
Uterine Atony = 80% of PPH
Uterus should feel like a "grapefruit" after delivery. Boggy, soft uterus = atony → bimanual compression immediately
T
Trauma
Lacerations, uterine rupture, haematoma
T
Tissue
Retained placenta / products
T
Thrombin
Coagulopathy, DIC
PPH Stepwise Management Protocol
- Call for help + note time. Activate PPH team. Assign roles.
- Bimanual uterine compression — one hand in vagina (anterior fornix), one hand on fundus abdominally. Compress and massage.
- Oxytocin 10 IU IV/IM stat — first-line uterotonic for all women; or oxytocin infusion 40 IU in 500 mL NS at 125 mL/hr
- IV access × 2 (large bore 14–16G). Bloods: FBC, coagulation screen, crossmatch, fibrinogen, U&E. Warm IV fluids.
- Ergometrine 500 mcg IM (or IV slowly). Contraindicated in hypertension/pre-eclampsia
- Carboprost (PGF2α) 250 mcg IM every 15 minutes, max 8 doses. Avoid in asthma
- Misoprostol 1000 mcg rectally if above agents have failed or unavailable
- Uterine tamponade: Bakri balloon (fill 300–500 mL saline) — check with USS before deflating
- Surgical options: B-Lynch compression suture, uterine artery ligation, internal iliac ligation
- Hysterectomy — life-saving; do not delay if bleeding uncontrolled. Discuss with patient and family where possible.
Massive Obstetric Haemorrhage — MTP Activation
Massive Transfusion Protocol (MTP)
Activate when estimated blood loss >2000 mL, ongoing haemorrhage, or haemodynamic instability not responding to initial resuscitation.
1:1:1 Resuscitation Ratio
- Packed Red Blood Cells (PRBC): 1 unit
- Fresh Frozen Plasma (FFP): 1 unit
- Platelets: 1 pooled unit (apheresis)
- Target: Hb >80 g/L, platelets >50×10⁹/L, fibrinogen >2 g/L
Tranexamic Acid (TXA)
WOMAN Trial Evidence
TXA 1g IV over 10 minutes as soon as PPH diagnosed. Second dose of 1g if bleeding continues at 30 minutes.
Must be given within 3 hours of birth — efficacy lost after 3 hours.
- Reduces PPH death by 31% (WOMAN trial, Lancet 2017)
- No increase in thromboembolic events
- Safe — give early, give always
CTG Interpretation — NICE Classification
| Feature | Normal (Green) | Non-Reassuring (Amber) | Abnormal (Red) |
|---|
| Baseline HR |
110–160 bpm |
100–109 or 161–180 bpm |
<100 or >180 bpm; rising baseline |
| Variability |
5–25 bpm |
<5 bpm for 40–90 min; >25 bpm for >25 min |
<5 bpm for >90 min; sinusoidal pattern |
| Accelerations |
≥2 in 20 min (≥15 bpm × ≥15 sec) |
Absence of accelerations (after 32 wks) |
Absent accelerations (non-reactive for >90 min) |
| Early decels |
Benign — head compression in labour |
— |
— |
| Variable decels |
Typical — <60 sec, quick recovery |
Atypical — slow return, loss of variability |
Atypical + late component; no recovery |
| Late decels |
— |
Occasional late decels with good variability |
Repeated late decels — uteroplacental insufficiency |
| Prolonged decel |
— |
Single 2–3 min (with recovery) |
≥3 minutes = EMERGENCY — call team |
CTG Action Rule (NICE)
Normal: All features reassuring — continue monitoring.
Suspicious: 1 non-reassuring feature — assess clinically, consider fetal scalp stimulation.
Pathological: 2+ non-reassuring OR 1 abnormal feature — urgent fetal blood sampling or expedite delivery.
Shoulder Dystocia
Turtle Sign: head delivers then retracts back against perineum
Bony dystocia of the fetal shoulder behind the maternal pubic symphysis. Window of safe delivery: 5–7 minutes. NEVER apply fundal pressure — it worsens impaction.
HELPERR Mnemonic — In Order
H
Help
Call team, note time, paediatrician
E
Episiotomy
Only if needed for internal manoeuvres — not for bony dystocia
L
Legs (McRoberts)
Hyperflex thighs onto abdomen — flattens lumbar lordosis, widens outlet
P
Pressure
Suprapubic pressure (Rubin I) — dislodge anterior shoulder
E
Enter
Internal rotational manoeuvres (Rubin II, Woods screw)
R
Remove
Deliver posterior arm — reduces shoulder-to-shoulder diameter
R
Roll
Gaskin manoeuvre — all-fours position; gravity assists posterior shoulder
After Resolution
Anticipate PPH (uterine atony from prolonged labour + Syntocinon bolus). Check neonate for brachial plexus injury (Erb's palsy), clavicle fracture, hypoxia. Document time of head delivery to full delivery, manoeuvres used, in order, with times.
Cord Prolapse
Umbilical cord presents before or alongside the fetal presenting part — compression cuts fetal oxygen supply
Immediate Actions
- Call for help — emergency CS team
- Nurse or doctor manually elevates presenting part off cord (gloved hand in vagina)
- Do NOT remove hand until CS begins
- Place patient in knee-chest or Trendelenburg position
- Fill bladder with 500 mL warm saline via IDC — elevates presenting part
- High-flow O₂ to mother
- Do NOT push cord back — keep moist with warm saline gauze
- Emergency CS — Category 1 (aim delivery within 30 min of diagnosis)
Risk Factors
- Artificial rupture of membranes (ARM) — especially if presenting part not engaged
- Malpresentation (footling breech, transverse lie)
- Polyhydramnios
- Multiple pregnancy — at delivery of second twin
- Prematurity (small presenting part)
- Low-lying placenta
GCC Maternity Statistics & Context
40–60%
CS rate in GCC private hospitals
30–40%
GDM prevalence in Gulf populations
Top 3
UAE/Saudi among highest IVF rates globally
Grand Multiparity (≥5 births)
- Higher in GCC due to cultural preference for large families and relatively low uptake of contraception in some communities
- Risks: uterine atony (PPH), placenta praevia, malpresentation
- Requires consultant-led care and active management of 3rd stage
Consanguinity & Genetic Screening
- First-cousin marriage rates: 25–50% in parts of Saudi Arabia, Qatar, UAE
- Increased risk of autosomal recessive conditions
- Thalassaemia (alpha and beta): mandatory pre-marital screening in several GCC states
- Sickle cell disease: carrier rates up to 4% in some Gulf populations
- Pre-conception genetic counselling important
Ramadan & Pregnancy
Clinical Position
WHO, RCOG, and the majority of Islamic scholars permit — and often advise — pregnant women to postpone fasting during Ramadan, particularly in the 2nd and 3rd trimesters. Nurses should support informed patient decision-making without coercion in either direction.
- Women with GDM who choose to fast face risk of hypoglycaemia (especially if on insulin or sulphonylureas) and post-iftar hyperglycaemia
- Advise: frequent BGL monitoring, break fast immediately if BGL <3.5 mmol/L or symptoms of hypoglycaemia
- Medication timing: discuss insulin dose adjustment with endocrinologist before Ramadan begins
- Dehydration risk in hot GCC climate: fetal movement monitoring important
- Women with severe pre-eclampsia, IUGR, or multiple pregnancy should be advised strongly against fasting
Cultural Birth Practices in GCC
- Female obstetrician preference: widely held in GCC — plan care to accommodate where possible; document preference on birth plan
- Male partner in delivery room: varies by family/nationality — some families prefer male partner absent; ask at booking, do not assume
- Privacy: paramount — ensure adequate draping, minimise staff entry, female chaperone with male doctors
- Azan after birth: call to prayer recited in newborn's ear — provide quiet space and time; this is a significant religious ritual
- Placenta: some families request placenta for burial — document request and follow local hospital policy
- Colostrum & breastfeeding: some cultural beliefs that colostrum is harmful — education with cultural sensitivity important
Female Genital Mutilation (FGM)
Relevant Patient Background in GCC
FGM is prevalent among patients from East Africa (Somalia, Eritrea, Ethiopia, Sudan, Egypt) — communities present in significant numbers across GCC as expatriate workers and their families.
- Classification (WHO): Type I–IV; Type III (infibulation — narrowing of vaginal opening) most relevant to obstetric care
- Antenatal assessment: sensitively identify FGM type at booking; referral to specialist midwife/obstetrician with FGM experience
- De-infibulation: recommended in 3rd trimester (28–32 weeks) or in early labour before full dilatation for Type III; under local anaesthetic
- Documentation: document clearly in maternal notes — use correct WHO terminology, not colloquialisms
- Safeguarding: if daughters present in household — safeguarding referral mandatory (illegal in UK, illegal in many GCC states); follow local hospital safeguarding protocol
- Re-infibulation: do NOT re-infibulate after delivery — illegal and unethical; explain to family if requested
Key GCC Maternity Employers
Latifa Hospital, Dubai (UAE)
The largest maternity hospital in the GCC — over 10,000 births per year. Part of Dubai Health. A primary employer of expatriate midwives and obstetric nurses.
Sidra Medicine, Doha (Qatar)
Qatar Foundation hospital; advanced tertiary maternity care; significant investment in high-risk obstetrics, NICU, and maternal-fetal medicine.
King Abdullah Medical Complex, Saudi Arabia
Major government maternity referral centre; high volume, high-acuity obstetrics; nurses follow MOH Saudi clinical guidelines.
Corniche Hospital, Abu Dhabi (UAE)
Dedicated maternity hospital in Abu Dhabi; HAAD accredited; strong NICU and obstetric emergency team training programmes.
Knowledge Check — 10 MCQ Quiz